Clinical Trials Unit-Rehman Medical Institute (CTU-RMI) is a Drug Regulatory Authority Pakistan (DRAP) Registered 1st Clinical Trials Unit in Khyber Pakhtunkhwa(KPK) recognized for its experience and expertise in the development and delivery of clinical trials and associated high-quality clinical research projects across a range of therapeutic areas. The unit leads primarily in the design, conduct, and analysis of national and international multi-centre trials, and the staff, with specialist disease and methodological knowledge, have input at all stages of the trial lifecycle.
This ensures that all activities are conducted according to the principles of ICH GCP and in compliance with the appropriate regulatory and ethical requirements. Clinical Trials Unit-RMI (CTU-RMI) is located within the Academic Blocks and Hospital buildings as a department, bringing together academic, clinical, and trial management expertise from across the Medical Institute and Colleges.
Additionally, CTU-RMI collaborates with members of the designated Academic Health Science Network and other national key clinical and scientific opinion leaders, other CTUs, and with the industry.
Our mission is to empower patients through ethical and impactful clinical research by establishing long-term strategic relationships with Contract Research Organisations (CROs) and other research organizations. Through collaborative efforts, we aim to drive health advancements globally.
The CTU-RMI has a primary goal of prioritising patients’ well-being and needs throughout the entire clinical research process. To achieve this, the CTU places patients at the center of their efforts, aiming to ensure their safety, comfort, and active participation in decision-making.
A patient-centered approach is at the core of CTU’s philosophy, which emphasises the importance of informed consent, individual autonomy, and protection of participant rights. To establish a foundation of trust, the unit maintains open communication with patients, their families, and the broader community. In pursuit of improved patient participation, the CTU takes steps to make information readily accessible, addresses patients’ concerns, and actively involves them as participants in the research process.
By adopting this patient-centered vision, the CTU strives to conduct ethical, high-quality clinical studies that not only produce valuable data but also generate results in compliance with Good Clinical Practice (GCP) guidelines. Ultimately, the unit’s efforts aim to benefit the participants and uphold the highest standards of research ethics.